Medtronic Defibrillator Lead Recall Attorneys
Medtronic Receives FDA Approval for Endeavor Zotarolimus-Eluting Coronary Stent System
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Marc Jay Bern
Profession: Defective Medical Device Lawyer
Category: Medtronic News
Medtronic announced they have received approval from the FDA for its Endeavor Zotarolimus-Eluting Coronary Stent System to be used in the treatment of coronary artery disease (CAD).
CAD is the leading cause of death in the United States and affects nearly thirteen million people.
The stent has been under study for quite some time now and has been used in over 4,100 patients that had been monitored for up to 4 years. Medtronic is expected to being manufacturing these stents immediately and the first batch should be done within the next 30 days.
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/2166